Methylprednisolone Acetate Injection — FDA Drug Shortage

Current — Amneal Pharmaceuticals

The FDA lists a drug shortage record for Methylprednisolone Acetate Injection (injection) from Amneal Pharmaceuticals with status Current. The shortage was first posted on Dec 15, 2021. Reported reason: Other

Shortage details

Status
Current
Company
Amneal Pharmaceuticals
Package NDC
70121-1573-1
Dosage Form
Injection
Presentation
Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1)
Initial Posting
Dec 15, 2021

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.